The proposed framework, which is label-free and rapid, can enable an early diagnosis, treatment, and prevention of liver diseases Peer-Reviewed Publication TOKYO UNIVERSITY OF SCIENCE IMAGE: BY COMBINING NEAR-INFRARED HYPERSPECTRAL IMAGING (NIR-HSI) WITH MACHINE LEARNING, RESEARCHERS FROM JAPAN SUCCESSFULLY VISUALIZED THE HYDROCARBON CHAIN LENGTH AND DEGREE OF SATURATION OF FATTY ACIDS IN MICE LIVERSCREDIT: MASAKAZU...
Neil Osterweil BOSTON — Patients with metabolic-associated steatotic liver disease (MASLD, formerly NAFLD) without cirrhosis who took daily low-dose aspirin in a double-blind randomized trial demonstated significant reductions in liver fat content over 6 months compared with similar patients who took a placebo, study results show. “In MASLD without cirrhosis, low-dose aspirin, 81 milligrams daily,...
by Diabetologia Credit: CC0 Public Domain New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year, found that the amount of fat stored in the liver is higher in people with type 2 diabetes (T2D), whatever their BMI. It also suggested that levels of liver fat currently...
In Phase II trial, treatment inhibited key enzyme, resulting in lowered triglyceride production and slower progression of non-alcoholic fatty liver disease to its more dangerous form: non-alcoholic steatohepatitis UNIVERSITY OF CALIFORNIA – SAN DIEGO Using a first-of-its-class drug in a clinical trial, an international research effort headed by a scientist at University of California San...
New research has uncovered genetic variations that may contribute to the development of non-alcoholic fatty liver disease (NAFLD), the leading cause of liver disease. Dr. Mayada Metwally looking down a microscope. Credit: The Westmead Institute for Medical Research NAFLD is major health concern in Western countries, with one in four people, including children, affected. The...
